P0224 : Nintedanib prevents the development of hepatocellular carcinoma in a mouse model of fibrosis

Victoria Tovar; A. Moeni; Sara Torrecilla; Mónica Higuera; Judit Peix; I.M. Quetglas; Leonardo Rodríguez‐Carunchio; Manel Solé; Josep M. Llovet

doi:10.1016/s0168-8278(15)30443-8

Related publications

Article2014

223 Preclinical assessment of nintedanib for chemoprevention in hepatocellular carcinoma

Victoria Tovar, Agrin Moeini, Sara Torrecilla, Mónica Higuera, Judit Peix, I.M. Quetglas, Leonardo Rodríguez‐Carunchio, Helena Cornellà, M Solé, Josep M. Llovet

European Journal of Cancer

Article2020

Cabozantinib enhances the efficacy and immune modulatory activity of anti-PD1 therapy in a syngeneic mouse model of hepatocellular carcinoma

Roger Esteban-Fabró, Catherine E. Willoughby, Marta Piqué‐Gili, Judit Peix, Carla Montironi, Jordi Abril‐Fornaguera, Laura Torrens, Roser Pinyol, Josep M. Llovet

Journal of Hepatology

Article2004

261 Exclusion of subcapsular tumors prevents peritoneal seeding in hepatocellular carcinoma (HCC) patients treated with radiofrequency

Fernando Pons, Mattia Squarcia, R. Vilana, Margaret Sala, Luca Bianchi, M García Ayuso, Marı́a Varela, Josep M. Llovet, C. Brú, Jordi Bruix

Journal of Hepatology

Article2009

A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma

Vincent W. Keng, Augusto Villanueva, Derek Y. Chiang, Adam J. Dupuy, Barbara J. Ryan, Ilze Matise, Kevin A.T. Silverstein, Aaron L. Sarver, Timothy K. Starr, Keiko Akagi, Lino Tessarollo, Lara S. Collier, Scott Powers, Scott W. Lowe, Nancy A. Jenkins, Neal G. Copeland, Josep M. Llovet, David A. Largaespada

Nature Biotechnology

Article2003

Hepatocellular carcinoma: a clinical update.

Fernando Pons-Renedo, Josep M. Llovet

PubMed